![XBiotech Inc](/common/images/company/N_XBIT.png)
XBiotech Inc is a United States based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for... XBiotech Inc is a United States based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States. Show more
AUSTIN, Texas, Dec. 23, 2024 (GLOBE NEWSWIRE) -- XBiotechΒ (NASDAQ: XBIT) announced today data that it is halting its clinical program in rheumatological disease while it seeks to understand the...
AUSTIN, Texas, June 18, 2024 (GLOBE NEWSWIRE) -- XBiotechΒ (NASDAQ: XBIT) announced today data from its Phase 1/Phase 2 randomized, double-blind, placebo-controlled multi-center study for...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.58 | -15.7608695652 | 3.68 | 3.69 | 3.1 | 55978 | 3.35730069 | CS |
4 | -0.87 | -21.9143576826 | 3.97 | 4.3 | 3.1 | 49697 | 3.61631156 | CS |
12 | -3.95 | -56.0283687943 | 7.05 | 7.64 | 3.1 | 70968 | 5.20072784 | CS |
26 | -3.5 | -53.0303030303 | 6.6 | 8.32 | 3.1 | 57299 | 6.02810487 | CS |
52 | -2.39 | -43.5336976321 | 5.49 | 9.96 | 3.1 | 72722 | 6.58623325 | CS |
156 | -6.66 | -68.237704918 | 9.76 | 10.5597 | 3 | 61138 | 5.9269809 | CS |
260 | -18.62 | -85.7274401473 | 21.72 | 25.8 | 3 | 99128 | 11.99409488 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.